{"Symbol": "AIXC", "AssetType": "Common Stock", "Name": "AIxCrypto Holdings, Inc.", "Description": "AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company is headquartered in Carlsbad, California.", "CIK": "1460702", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "TECHNOLOGY", "Industry": "SOFTWARE - INFRASTRUCTURE", "Address": "5857 OWENS AVENUE, CARLSBAD, CA, UNITED STATES, 92008", "OfficialSite": "https://www.aixcrypto.ai", "FiscalYearEnd": "December", "LatestQuarter": "None", "MarketCapitalization": "None", "EBITDA": "None", "PERatio": "None", "PEGRatio": "None", "BookValue": "None", "DividendPerShare": "None", "DividendYield": "None", "EPS": "None", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "0", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "-", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "None", "52WeekHigh": "6.48", "52WeekLow": "1.16", "50DayMovingAverage": "0", "200DayMovingAverage": "0", "SharesOutstanding": "0", "SharesFloat": "0", "PercentInsiders": "0.000", "PercentInstitutions": "0.000", "DividendDate": "None", "ExDividendDate": "None"}